ROLE FOR DUAL INDIVIDUALIZATION WITH CEFMENOXIME

被引：112

作者：

SCHENTAG, JJ

SMITH, IL

SWANSON, DJ

DEANGELIS, C

FRACASSO, JE

VARI, A

VANCE, JW

机构：

[1] MILLARD FILLMORE HOSP,DEPT MED,BUFFALO,NY 14209

[2] SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260

来源：

AMERICAN JOURNAL OF MEDICINE | 1984年 / 77卷 / 6A期

关键词：

D O I：

10.1016/S0002-9343(84)80074-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：43 / 50

页数：8

共 11 条

[1]

DRUSANO GL, 1984, REV INFECT DIS, V6, P357

[2]

ELLNER PD, 1981, JAMA-J AM MED ASSOC, V246, P575

[3]

FREEMAN J, 1984, REV INFECT DIS, V6, P285

[4]

Gibaldi M, 1982, PHARMACOKINETICS, V15, P445

[5]

REITBERG DP, 1983, CLIN CHEM, V29, P1415

[6] CEFMENOXIME IN THE TREATMENT OF NOSOCOMIAL PNEUMONIAS IN CRITICAL CARE PATIENTS [J].

REITBERG, DP ;

CUMBO, TJ ;

SCHENTAG, JJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (01) :81-91

[7] PRINCIPLES OF ANTIBIOTIC TISSUE PENETRATION AND GUIDELINES FOR PHARMACOKINETIC ANALYSIS [J].

SCHENTAG, JJ ;

GENGO, FM .

MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (01) :39-49

[8]

SCHENTAG JJ, CLIN PHARM THER

[9]

SCHENTAG JJ, J ANTIMICROB CHEMOTH

[10]

SCHUMACHER G E, 1982, Clinical Pharmacy, V1, P66

← 1 2 →